NCT04489017View on ClinicalTrials.gov

Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

June 30, 2023

Conditions
Frontotemporal Dementia
Interventions
DIETARY_SUPPLEMENT

PEA-LUT

PEA-LUT administration at the oral dosage of 700 mg x 2/day

DIETARY_SUPPLEMENT

PLACEBO

PLACEBO administration at the oral dosage of 700 mg x 2/day

Trial Locations (2)

00179

Giacomo Koch, Rome

Santa Lucia Foundation, Rome

All Listed Sponsors
lead

I.R.C.C.S. Fondazione Santa Lucia

OTHER

NCT04489017 - Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter